<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Csv>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE296nnn/GSE296401/suppl/GSE296401_CHD1_2D2_EAE_CNS.csv.gz</Csv><Csv>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE296nnn/GSE296401/suppl/GSE296401_GR_2D2_EAE_CNS.csv.gz</Csv><Csv>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE296nnn/GSE296401/suppl/GSE296401_CHD1_2D2_EAE_dLN.csv.gz</Csv><Csv>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE296nnn/GSE296401/suppl/GSE296401_IL23R_WT_KO_Ctrl_Dex.csv.gz</Csv><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE296nnn/GSE296401/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296401</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Interleukin-23 promotes a pro-inflammatory Th17 cell state by stabilizing RORγt and suppressing glucocorticoid receptor activity II</name><description>Interleukin-23 receptor (IL-23R) signaling is critical for the generation of pro-inflammatory CD4+ IL-17-producing T cells (Th17) that can drive autoimmune tissue inflammation, but the underlying mechanisms are not clear. We integrated phosphoproteomic and transcriptomic data downstream of IL-23R and IL-12R, which share a common subunit, to identify mechanisms engaged specifically by IL-23. We identified chromodomain helicase DNA-binding protein 1 (CHD1), an epigenetic regulator, and the glucocorticoid receptor (GR), a transcription factor (TF), as mediators of IL-23R signaling. IL-23R activation promoted CHD1 interaction with TF STAT3 and co-binding at the TF RORγt locus to enforce a pro-inflammatory Th17 state. Conversely, IL-23R signaling altered phosphorylation of the GR, thereby preventing its activation and nuclear translocation, ultimately impairing GR-driven inhibition of pro-inflammatory Th17 gene programs. Our findings uncover two mechanisms by which IL-23 promotes a pro-inflammatory Th17 cell state, offering potential therapeutic targets for treating Th17-driven autoimmune tissue inflammation and restoring homeostasis.</description><dates><publication>2026/06/12</publication></dates><accession>GSE296401</accession><cross_references><GSM>GSM8969703</GSM><GSM>GSM8969669</GSM><GSM>GSM8969702</GSM><GSM>GSM8969688</GSM><GSM>GSM8969666</GSM><GSM>GSM8969687</GSM><GSM>GSM8969668</GSM><GSM>GSM8969701</GSM><GSM>GSM8969700</GSM><GSM>GSM8969689</GSM><GSM>GSM8969667</GSM><GSM>GSM8969684</GSM><GSM>GSM8969683</GSM><GSM>GSM8969686</GSM><GSM>GSM8969685</GSM><GSM>GSM8969680</GSM><GSM>GSM8969682</GSM><GSM>GSM8969681</GSM><GSM>GSM8969677</GSM><GSM>GSM8969699</GSM><GSM>GSM8969698</GSM><GSM>GSM8969676</GSM><GSM>GSM8969679</GSM><GSM>GSM8969678</GSM><GSM>GSM8969695</GSM><GSM>GSM8969673</GSM><GSM>GSM8969694</GSM><GSM>GSM8969672</GSM><GSM>GSM8969697</GSM><GSM>GSM8969675</GSM><GSM>GSM8969674</GSM><GSM>GSM8969696</GSM><GSM>GSM8969691</GSM><GSM>GSM8969690</GSM><GSM>GSM8969671</GSM><GSM>GSM8969693</GSM><GSM>GSM8969692</GSM><GSM>GSM8969670</GSM><GPL>19057</GPL><GPL>21626</GPL><GSE>296401</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>